Amniotic Membrane Induces Peroxisome Proliferator-Activated Receptor-γ Positive Alternatively Activated Macrophages

被引:27
|
作者
Bauer, Dirk [1 ]
Hennig, Maren [1 ,2 ]
Wasmuth, Susanne [1 ]
Baehler, Hanna [1 ]
Busch, Martin [1 ,2 ]
Steuhl, Klaus-Peter [2 ]
Thanos, Solon [3 ]
Heiligenhaus, Arnd [1 ]
机构
[1] St Franziskus Hosp, Dept Ophthalmol, Ophtha Lab, D-48145 Munster, Germany
[2] Univ Duisburg Essen, Dept Ophthalmol, Essen, Germany
[3] Univ Munster, Sch Med, Inst Expt Ophthalmol, Munster, Germany
关键词
NF-KAPPA-B; APOPTOTIC CELLS LEADS; HERPES-SIMPLEX; PPAR-GAMMA; OXIDIZED LDL; SIGNALING PATHWAYS; STROMAL KERATITIS; LIPID-METABOLISM; HUMAN CORNEAL; NITRIC-OXIDE;
D O I
10.1167/iovs.11-7617
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Amniotic membrane transplantation (AMT) reportedly improves herpetic stromal keratitis (HSK). Here we studied the role of the amniotic membrane (AM) on macrophages. METHODS. BALB/c mice with necrotizing HSK received an AMT or tarsorrhaphy (TAR) as control. Apoptosis of F4/80+ cells was determined using the annexinV/7-AAD system. Macrophage invasion was determined using a cornea invasion assay. Cytokine secretion was quantified by ELISA. Arginase activity was measured by bioassay. Expression of nuclear factor (NF)-kappa B or peroxisome proliferator-activated receptor (PPAR)-gamma related proteins was detected by Western blot analysis, and the expression of costimulatory surface molecules or PPAR-gamma by flow cytometry. Lipid accumulation was observed by Oil red O and Sudan B staining. RESULTS. After AMT apoptotic features of corneal macrophages, but also macrophage invasion increased. IL-6, IL-10, IL-12, TNF-alpha, and NF-kappa B content in HSK corneas had decreased with AMT. AMT increased expression of PPAR-gamma, arginase 1 and 2, and arginase activity in AM-treated HSK corneas. In vitro, NF-kappa B, cytokine production, costimulatory molecules (CD80, CD86, CD40), phagocytic capacity, proliferation, viability, and accessory function to herpes simplex virus (HSV)-1 specific draining lymph node (DLN) cells were reduced in bone marrow derived macrophages (BM) cocultured with AM, while CD206, CD204, CD163, and CD68, lipid accumulation in the cytoplasm, PPAR-gamma expression, and arginase activity was increased. An increase in viability and proliferation was observed in the presence of AM combined with apoptotic cells, compared with AM alone. CONCLUSIONS. Based on these results it can be concluded that the action mechanism of AM is associated with modulation of classically activated macrophages into alternatively activated macrophages or macrophage cell death, probably by engaging lipid metabolism and activating the PPAR-gamma pathway, consequently curtailing effector T cell functions. Apoptotic cells induced in the environment with AM support the presence and survival of such macrophages. (Invest Ophthalmol Vis Sci. 2012; 53: 799-810) DOI: 10.1167/iovs.11-7617
引用
收藏
页码:799 / 810
页数:12
相关论文
共 50 条
  • [21] Telmisartan Exerts Antiatherosclerotic Effects by Activating Peroxisome Proliferator-Activated Receptor-γ in Macrophages
    Matsumura, Takeshi
    Kinoshita, Hiroyuki
    Ishii, Norio
    Fukuda, Kazuki
    Motoshima, Hiroyuki
    Senokuchi, Takafumi
    Taketa, Kayo
    Kawasaki, Shuji
    Nishimaki-Mogami, Tomoko
    Kawada, Teruo
    Nishikawa, Takeshi
    Araki, Eiichi
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (06) : 1268 - U52
  • [22] Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
    Lin Wang
    Yin Cai
    Liguo Jian
    Chi Wai Cheung
    Liangqing Zhang
    Zhengyuan Xia
    Cardiovascular Diabetology, 20
  • [23] The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
    Li, Jingjing
    Guo, Chuanyong
    Wu, Jianye
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2619 - 2628
  • [24] Lipid metabolism:: peroxisome proliferator-activated receptor-α and atherosclerosis
    van Greevenbroek, MMJ
    van der Kallen, CJH
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (02) : 223 - 225
  • [25] Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
    Wang, Lin
    Cai, Yin
    Jian, Liguo
    Cheung, Chi Wai
    Zhang, Liangqing
    Xia, Zhengyuan
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [26] Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation
    Bishop-Bailey, David
    Bystrom, Jonas
    PHARMACOLOGY & THERAPEUTICS, 2009, 124 (02) : 141 - 150
  • [27] Diclofenac antagonizes peroxisome proliferator-activated receptor-γ signaling
    Adamson, DJA
    Frew, D
    Tatoud, R
    Wolf, CR
    Palmer, CNA
    MOLECULAR PHARMACOLOGY, 2002, 61 (01) : 7 - 12
  • [28] Role of Peroxisome Proliferator-Activated Receptor-γ in Atherosclerosis - An Update
    Wang, Nanping
    Yin, Ruiying
    Liu, Yan
    Mao, Guangmei
    Xi, Fang
    CIRCULATION JOURNAL, 2011, 75 (03) : 528 - 535
  • [29] Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis
    Yang, Liu
    Chan, Che-Chang
    Kwon, Oh-Sang
    Liu, Songling
    McGhee, Jason
    Stimpson, Stephen A.
    Chen, Lihong Z.
    Harrington, W. Wallace
    Symonds, William T.
    Rockey, Don C.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (05): : G902 - G911
  • [30] Peroxisome proliferator-activated receptor-γ in macrophage lipid homeostasis
    Lee, CH
    Evans, RM
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (08): : 331 - 335